发明公开
EP1276711A2 SYNTHESIS OF MIDODRINE HCI FROM A NOVEL INTERMEDIATE 1-(2',5'-DIMETHOXYPHENYL)-2-AZIDOETHANONE 有权
盐酸米多君的合成从中间1-(2'.5'二甲氧基苯基)-2-叠氮基乙酮

  • 专利标题: SYNTHESIS OF MIDODRINE HCI FROM A NOVEL INTERMEDIATE 1-(2',5'-DIMETHOXYPHENYL)-2-AZIDOETHANONE
  • 专利标题(中): 盐酸米多君的合成从中间1-(2'.5'二甲氧基苯基)-2-叠氮基乙酮
  • 申请号: EP01931614.0
    申请日: 2001-04-17
  • 公开(公告)号: EP1276711A2
    公开(公告)日: 2003-01-22
  • 发明人: RAY, Anup KumarPATEL, Hiren Kumar V.PATEL, Mahendra, R.
  • 申请人: Novartis AG
  • 申请人地址: Lichtstrasse 35 4056 Basel CH
  • 专利权人: Novartis AG
  • 当前专利权人: Novartis AG
  • 当前专利权人地址: Lichtstrasse 35 4056 Basel CH
  • 代理机构: Gros, Florent
  • 优先权: US550417 20000417
  • 国际公布: WO01079154 20011025
  • 主分类号: C07C231/14
  • IPC分类号: C07C231/14 C07C237/08 C07C247/10
SYNTHESIS OF MIDODRINE HCI FROM A NOVEL INTERMEDIATE 1-(2',5'-DIMETHOXYPHENYL)-2-AZIDOETHANONE
摘要:
Midodrine hydrochloride, ± 1-(2',5'-dimethoxyphenyl)-2-glycineamido-ethanol-(1)- HCI, is prepared from a novel intermediate, 1-(2',5'-dimethoxyphenyl)-2-azidoethanone.
信息查询
0/0